UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

Obstetrics and gynecology (New York. 1953), 2012-01, Vol.119 (1), p.61-67

2012

Link zum Volltext

Verfügbarkeit prüfen

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Cancer, 2013-01, Vol.119 (2), p.325-331

2013

Link zum Volltext

Verfügbarkeit prüfen

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153

2010

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5546-5553

2004

Link zum Volltext

Verfügbarkeit prüfen

Assessing gynecologic and breast cancer survivors' sexual health care needs

Cancer, 2011-06, Vol.117 (12), p.2643-2651

2011

Link zum Volltext

Verfügbarkeit prüfen

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Link zum Volltext

Verfügbarkeit prüfen

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2002-04, Vol.52 (5), p.1330-1337

2002

Link zum Volltext

Verfügbarkeit prüfen

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2002-12, Vol.54 (5), p.1388-1396

2002

Link zum Volltext

Verfügbarkeit prüfen

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

International journal of radiation oncology, biology, physics, 2003-10, Vol.57 (2), p.516-521

2003

Link zum Volltext

Verfügbarkeit prüfen

Outcome and patterns of failure in pathologic stages I–IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2003-04, Vol.55 (5), p.1272-1276

2003

Link zum Volltext

Verfügbarkeit prüfen

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2003-11, Vol.57 (4), p.1004-1009

2003

Link zum Volltext

Verfügbarkeit prüfen

Stage IIIC Small Cell Carcinoma of the Ovary: Survival With Conservative Surgery and Chemotherapy

Obstetrics and gynecology (New York. 1953), 2004-05, Vol.103 (5, Part 2 Suppl), p.1120-1123

2004

Link zum Volltext

Verfügbarkeit prüfen

Pathologic stage I-II endometrial carcinoma in the elderly: Radiotherapy indications and outcome

International journal of radiation oncology, biology, physics, 2004-08, Vol.59 (5), p.1432-1438

2004

Link zum Volltext

Verfügbarkeit prüfen

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988–1995

Obstetrics and gynecology (New York. 1953), 2001-02, Vol.97 (2), p.248-254

2001

Link zum Volltext

Verfügbarkeit prüfen

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009-11, Vol.175 (5), p.2184-2196

2009

Link zum Volltext

Verfügbarkeit prüfen

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1145-1153

2001

Link zum Volltext

Verfügbarkeit prüfen

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

Cancer, 2000-06, Vol.88 (12), p.2782-2786

2000

Link zum Volltext

Verfügbarkeit prüfen

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

Gynecologic oncology, 2001-09, Vol.82 (3), p.456-463

2001

Link zum Volltext

Verfügbarkeit prüfen

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1154-1160

2001

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Carcinoma Cell Cultures Are Resistant to TGF-β1-Mediated Growth Inhibition Despite Expression of Functional Receptors

Gynecologic oncology, 1999-10, Vol.75 (1), p.72-77

1999

Link zum Volltext

Verfügbarkeit prüfen

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Link zum Volltext

Verfügbarkeit prüfen

Outcome and Management of Pathological Stage I Endometrial Carcinoma Patients with Involvement of the Lower Uterine Segment

Gynecologic oncology, 2001-12, Vol.83 (3), p.513-517

2001

Link zum Volltext

Verfügbarkeit prüfen

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2000-12, Vol.48 (5), p.1613-1621

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Publishing

KollektionSpringer Nature - Connect here FIRST to enable access

ThemaOvarian Neoplasms - Pathology

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer

Assessing gynecologic and breast cancer survivors' sexual health care needs

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies

Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy

Outcome and patterns of failure in pathologic stages I–IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

Outcome and pattern of failure in pathologic stage I–II papillary serous carcinoma of the endometrium: Implications for adjuvant radiation therapy

Stage IIIC Small Cell Carcinoma of the Ovary: Survival With Conservative Surgery and Chemotherapy

Pathologic stage I-II endometrial carcinoma in the elderly: Radiotherapy indications and outcome

Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988–1995

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma

Ovarian Carcinoma Cell Cultures Are Resistant to TGF-β1-Mediated Growth Inhibition Despite Expression of Functional Receptors

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Outcome and Management of Pathological Stage I Endometrial Carcinoma Patients with Involvement of the Lower Uterine Segment

Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies

Aktive Filter

Suchergebnisse filtern